Article and Video CATEGORIES

Cancer Journey

Search By

Ana Velazquez Mañana is a medical oncology fellow at UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco and former Chief Resident at Mount Sinai Beth Israel in New York City.

2020 PEA Program Velazquez, Franco COVID Parte 2 Reacciones Comunes a la Vacuna Contra el Coronavirus
Parte 2 // Part 2: ¿Cuáles son las reacciones más comunes que puedo tener después de la vacuna contra el coronavirus? // What are the most common reactions that I can experience after the vaccine against the coronavirus?
Author
Ana Velazquez Mañana, MD MSc
Image
Parte 2 // Part 2: ¿Cuáles son las reacciones más comunes que puedo tener después de la vacuna contra el coronavirus? // What are the most common reactions that I can experience after the vaccine against the coronavirus?

Drs. Ana Velázquez e Ivy Franco, participantes en el Programa de Embajadores de Educación para Pacientes GRACE de este año pasado, tienen una discusión para nuestra comunidad de habla hispana sobre el Virus Corona.

Para este video, los doctores Velázquez y Franco analizan las reacciones más comunes experimentadas después de recibir la vacuna.

 

¡Muchas gracias a nuestros patrocinadores #Lilly y #Genentech!

 

Para unirse a la conversación, visite https://cancergrace.org/forum.

****

Drs. Ana Velazquez and Ivy Franco, participants in this past year's GRACE Patient Education Ambassador Program, have a discussion for our Spanish-speaking community on the Corona Virus.

For this video, Drs Velazquez and Franco discuss the most common reactions experienced after getting the vaccine.

 

Many thanks to our sponsors #Lilly and #Genentech!

 

To join the conversation, visit https://cancergrace.org/forum.

Video Language

Next Previous link

Previous PostNext Post

Related Content

Image
Trial data ASCO 2024
Video
In this video series from ASCO 2024, Drs. Aakash Desai and Fauwzi Abu Rous discuss trial dates and clinical data as presented at the 2024 ASCO. To watch the complete playlist, click here.         
Image
Bladder Cancer Video Library 2024
Video
Dr. Petros Grivas discusses intravesical treatment for patients with nonmuscle invasive, or early-stage, bladder cancer, the importance of participating in clinical trials for bladder cancer, combination therapy options for patients with metastatic or incurable bladder cancer, and the importance of family history of cancer and discussing that history with your doctor.
Image
Case Based Panel
Video
The panel discusses treatment options for a patient diagnosed with EGFR Exon 19 Deletion NSCLC and examines data from the Laura Trial, a patient with a smoking history and diagnosis of small cell lung cancer, and how the Adriatic Study factors into decisions, and a patient with NSCLC adenocarcinoma, and a EGFR Exon 21 L858R Alteration, and how data from the Flaura 2 Trial can impact treatment decisions.

Forum Discussions

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Hi elysianfields,

 

That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...

Hello Linda, my name is Alexandra Beneke, I'm the Outreach Manager for GRACE. Your willingness to share your experiences and knowledge with the cancer community is truly inspiring. Your dedication to...

Recent Comments

JOIN THE CONVERSATION
I could not find any info on…
By JanineT GRACE … on
Hi elysianfields,

 

That's…
By JanineT GRACE … on
Hello Janine, thank you for…
By elysianfields on
EGFR
By happybluesun on